Candidiasis, Invasive Completed Phase 2 Trials for Fluconazole (DB00196)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

DBCOND0036184 (Candidiasis, Invasive)Completed2 IdentifierTitlePurposeDrugs
NCT02244606Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisTreatment
NCT02734862CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionTreatment